Skip to main content

Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies

Frank S, Persse T, Coleman I, Bankhead III A, Li D, De-Sarkar N, Wilson D, Rudoy D, Vashisth M, Galipeau P, Yang M, Hanratty B, Dumpit R, Morrissey C, Corey E, Montgomery RB, Haffner MC, Pritchard CC, Vasioukhin V, Ha G, Nelson PS
eLife 2025 (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
208342pLenti-Cas9.mCherryLentivirus with EF1a driven Cas9 linked (P2A) to mCherry.
208343pLCV2-AAVS1(hU6-sg1-mU6-sg2)-BlastpLentiCRISPRv2-Blast backbone with two separate sgRNAs against AAVS1. Serves as a negative control by targeting a safe harbor locus.
208344pLCV2-CDK12(hU6-sg2-mU6-sg3)-BlastpLentiCRISPRv2-Blast backbone with two separate sgRNAs against CDK12
208346pCR8-CDK12(sgR)Gateway cloning entry vector with CDK12 with sgRNA resistant silent mutations. Must be recombined into a DEST vector for expression.
208347pCR8-CDK12Gateway cloning entry vector with CDK12. Must be recombined into a DEST vector for expression.
208348pLCV2-CDK13(hU6-sg2-mU6-sg3)-BlastpLentiCRISPRv2-Blast backbone with two separate sgRNAs against CDK13
208349pLenti-sgStuffer-GFP-PuroLentivirus sgRNA backbone with GFP and PuroR. Compatible with golden gate cloning (Esp3i/BsmBI)
208350pLenti-sgStuffer-mCherry-PuroLentivirus sgRNA backbone with mCherry and PuroR. Compatible with golden gate cloning (Esp3i/BsmBI)
208408FUCGW-DESTLentivirus compatible with LR Gateway cloning for UBC-driven gene expression with CMV-GFP in backbone
208409FUCRW-DESTLentivirus compatible with LR Gateway cloning for UBC-driven gene expression with CMV-RFP in backbone

Antibodies from Article